Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 16, 2018 - Issue 8
Submit an article Journal homepage
1,586
Views
0
CrossRef citations to date
0
Altmetric
Editorial

A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies

Richard R. WatkinsDivision of Infectious Diseases, Cleveland Clinic Akron General, Akron, OH, USA;Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio, USACorrespondence[email protected]
View further author information
Pages 591-593 | Received 03 Jun 2018, Accepted 18 Jul 2018, Published online: 25 Jul 2018

References

  • Bulens SN, Yi SH, Walters MS, et al. Carbapenem-nonsusceptible Acinetobacter baumannii, 8 US metropolitan areas, 2012-2015. Emerg Infect Dis. 2018 Apr;24(4):727–734.
  • Lemos EV, de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014 May;20(5):416–423.
  • Thorpe KE, Joski P, Johnston KJ. Antibiotic-Resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff (Millwood). 2018 Apr;37(4):662–669.
  • Paul M, Daikos GL, Durante-Mangoni E, et al. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis. 2018 Apr;18(4):391–400.
  • El Chakhtoura NG, Saade E, Iovleva A, et al. Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward ‘molecularly targeted’ therapy. Expert Rev Anti Infect Ther. 2018 Feb;16(2):89–110.
  • Shin B, Park W. Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy. J Microbiol. 2017 Nov;55(11):837–849.
  • Armand-Lefèvre L, Angebault C, Barbier F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013 Mar;57(3):1488–1495.
  • Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol. 2015 Jun;53(6):1986–1989.
  • Leung V, Vincent C, Edens TJ, et al. Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent clostridium difficile infection. Clin Infect Dis. 2018 Jan 18;66(3):456–457.
  • Chiang MH, Sung WC, Lien SP, et al. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology. Hum Vaccin Immunother. 2015;11(4):1065–1073.
  • Huang W, Wang, S, Yao Y, et al. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection. Sci Rep. 2016 Nov;16(6):37242.
  • Schooley RT, Biswas B, Gill JJ, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017 Sep 22;61(10).
  • LaVergne S, Hamilton T, Biswas B, et al. Phage therapy for a multidrug-resistant Acinetobacter baumannii craniectomy site infection. Open Forum Infect Dis. 2018 Mar 23;5(4):ofy064.
  • Goel VK, Kapil A. Monoclonal antibodies against the iron regulated outer membrane proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol. 2001;1:16.
  • Nielsen TB, Pantapalangkoor P, Luna BM, et al. Monoclonal antibody protects against Acinetobacter baumannii infection by enhancing bacterial clearance and evading sepsis. J Infect Dis. 2017 Aug 15;216(4):489–501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.